Preclinical News and Research

RSS

Researcher receives 2013 Victoria Prize for contributions in quest to eradicate malaria

Malaria researcher Professor Alan Cowman from the Walter and Eliza Hall Institute has been awarded the 2013 Victoria Prize for Science and Innovation in recognition of his outstanding contributions in the quest to eradicate malaria.

8 Oct 2013

Two researchers receive $2.5M grant to continue their research on cancer cell growth

A pair of researchers at Rutgers Cancer Institute of New Jersey has been awarded nearly $2.5 million dollars to further study in their respective laboratories.

8 Oct 2013

Researchers identify protein that triggers inflammation in patients with hemorrhage, sepsis

Investigators at The Feinstein Institute for Medical Research have discovered a protein in the human body that can trigger and mediate inflammation in patients suffering from hemorrhage and sepsis. The findings were published in the online version of Nature Medicine on October 6, 2013.

7 Oct 2013

Glutamergic agents may be used as novel treatment for mood and anxiety disorders

Glutamergic agents may one day be used as a novel treatment for mood and anxiety disorders, new research presented at the 26th ECNP Congress suggests.

7 Oct 2013

New therapeutic targets and drugs may benefit people with leukemia

An Indiana University cancer researcher and his colleagues have discovered new therapeutic targets and drugs that may someday benefit people with certain types of leukemia or blood cancer.

5 Oct 2013

Autism Speaks launches the Preclinical Autism Consortium for Therapeutics

Autism Speaks, the world's leading autism science and advocacy organization, today announced the launch of the Preclinical Autism Consortium for Therapeutics (PACT).

4 Oct 2013

Cholesterol-lowering drugs could be alternative treatment for people who take statins

A new class of cholesterol-lowering drugs that target a recently discovered regulator of harmful cholesterol could be an alternative or complementary treatment for the 30 million people who take statins, after the first trial in humans confirms the technique’s feasibility and safety.

4 Oct 2013

Researchers suggest new view of how stem cells may help repair brain following trauma

University of South Florida researchers have suggested a new view of how stem cells may help repair the brain following trauma. In a series of preclinical experiments, they report that transplanted cells appear to build a "biobridge" that links an uninjured brain site where new neural stem cells are born with the damaged region of the brain.

4 Oct 2013

Researchers to develop treatments that may aid in optimal recovery of military from combat injuries

Researchers with Jefferson Orthopedics are using their experience and expertise in post-traumatic joint stiffness to develop treatments that could aid in optimal recovery and restoration of joint function for members of the military who sustain traumatic combat or combat-related injuries.

4 Oct 2013

J&J's Janssen Companies Launch A Trio Of Collaborations

...

3 Oct 2013

CureVac collaborates with Janssen on development of influenza vaccine based on mRNA

CureVac, a clinical stage biopharmaceutical company that has pioneered the development of a new class of therapies and vaccines based on messenger RNA (mRNA), today announced that it has entered into a collaboration and licensing agreement with Janssen Pharmaceuticals, Inc. Under the agreement CureVac will collaborate with Crucell Holland B.V. (a member of the Janssen Pharmaceutical Companies) on the development of an influenza vaccine based on CureVac's RNActive® technology.

3 Oct 2013

Final patient completion of phase II study of TR040303 in patients treated for acute myocardial infarction announced by Trophos

Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, announces today the final patient completion of a phase II study of TR040303 in patients treated for acute myocardial infarction (MI). Outcome data of this study is expected to be available towards the end of 2013.

2 Oct 2013

Research reveals significant role of Axl receptor in progression, therapeutic resistance of AML

BerGenBio AS, an oncology biopharmaceutical company, announces that a paper entitled "Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine cross-talk of leukemia cells with bone marrow stroma" by Ben-Batalla et al., has been published in Blood, the most cited peer-reviewed research journal in the field of hematology.

1 Oct 2013

MD Anderson-developed aerosol triggers innate immunity to squelch infections

Research on an aerosol that jump-starts a rapid immune response to stifle viral respiratory infections before they can provoke asthma attacks has earned major funding from the National Institutes of Health.

1 Oct 2013

Pfizer Licenses Gliknik's Pooled IVIG In $25M+ Deal

...

30 Sep 2013

Viewpoints: Gerson says no compromises make for 'bad politics;' Democrats are getting a pass; Manchin signals a break in Democratic ranks

We are seeing that an anti-compromise ideology can make for bad politics. In our system, Obamacare will not be overturned by one house of Congress. A tea-party shutdown strategy - if implemented - would make securing the other house and the presidency less likely for Republicans. And the political energy consumed by Cruz and crew has not been available to promote incremental limits on Obamacare that might have aided GOP political prospects (Michael Gerson, 9/26).

30 Sep 2013

SBIR Awards Etubics $1.5M To Manufacture Breast Cancer Immunotherapy

...

27 Sep 2013

Immunologic checkpoint inhibitor shows promise in malignant mesothelioma

Tremelimumab, one of a new class of immunomodulatory monoclonal antibodies, has shown encouraging clinical activity and acceptable tolerability in patients with chemotherapy-resistant malignant mesothelioma, results of a single-arm phase II study show.

27 Sep 2013

Study: Antidepressant drugs prove to be effective against SCLC patients

A bioinformatics approach to repurposing drugs resulted in identification of a class of antidepressants as a potential new treatment for small-cell lung cancer (SCLC), according to a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

27 Sep 2013

FDA awards grants to boost development, availability of medical devices for children

The U.S. Food and Drug Administration today announced it has awarded seven grants totaling more than $3.5 million to various pediatric device consortia to boost the development and availability of medical devices for children.

26 Sep 2013

Preclinical News and Research

Researcher receives 2013 Victoria Prize for contributions in quest to eradicate malaria

Two researchers receive $2.5M grant to continue their research on cancer cell growth

Researchers identify protein that triggers inflammation in patients with hemorrhage, sepsis

Glutamergic agents may be used as novel treatment for mood and anxiety disorders

New therapeutic targets and drugs may benefit people with leukemia

Autism Speaks launches the Preclinical Autism Consortium for Therapeutics

Cholesterol-lowering drugs could be alternative treatment for people who take statins

Researchers suggest new view of how stem cells may help repair brain following trauma

Researchers to develop treatments that may aid in optimal recovery of military from combat injuries

J&J's Janssen Companies Launch A Trio Of Collaborations

CureVac collaborates with Janssen on development of influenza vaccine based on mRNA

Final patient completion of phase II study of TR040303 in patients treated for acute myocardial infarction announced by Trophos

Research reveals significant role of Axl receptor in progression, therapeutic resistance of AML

MD Anderson-developed aerosol triggers innate immunity to squelch infections

Pfizer Licenses Gliknik's Pooled IVIG In $25M+ Deal

Viewpoints: Gerson says no compromises make for 'bad politics;' Democrats are getting a pass; Manchin signals a break in Democratic ranks

SBIR Awards Etubics $1.5M To Manufacture Breast Cancer Immunotherapy

Immunologic checkpoint inhibitor shows promise in malignant mesothelioma

Study: Antidepressant drugs prove to be effective against SCLC patients

FDA awards grants to boost development, availability of medical devices for children

New Approach Methodologies, the 3Rs and Multimodal Imaging in Preclinical Research - eBook eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics